Charles River Laboratories Intl. Inc vs Public Storage — how do they compare? Charles River Laboratories Intl. Inc trades at $297.28 (market cap $14.23B), while Public Storage trades at $285.55 (market cap $53.35B). The key difference: Public Storage is far larger — about 3.7× Charles River Laboratories Intl. Inc's market cap, and Public Storage pays a 4.2% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Public Storage for 130 Days on average.
| CRL | PSA | |
|---|---|---|
Market Cap | $14.23B | $53.35B |
Volume | 1,176,885 | 1,176,034 |
Sector | Health | Real Estate |
52-Week High | $310.77 | $330.47 |
52-Week Low | $149.93 | $258.44 |
Typical Hold Time | 33 Days | 130 Days |
Enterprise Value | $17.06B | $67.62B |
Dividend Yield | — | 4.2% |
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $300.30, down 1.53% on the day, with strong analyst support showing 73% buy ratings and a $305.50 consensus target. The stock maintains a bullish technical signal with support at $295 and resistance at $306. Recent earnings have consistently beaten expectations, though the company faces profitability challenges with negative net income margins and elevated valuation multiples.
While CRL shows promising growth initiatives including 5-7% revenue targets and $300M savings by 2030, investors face risks from negative profitability, high debt levels, and premium valuations. The stock's near-term catalyst will be Q3 2026 earnings against $2.97 EPS expectations, with technical positioning suggesting limited downside from current levels.
Public Storage (PSA) trades at $281.99, down 1.35% on the day, with a bearish technical signal and mixed sentiment. The stock exhibits strong profitability with a 41.8% net income margin and consistent earnings beats, but faces headwinds from negative net cash flow trends. Recent developments include the completion of the Public Storage Canada acquisition and a $400 million senior notes offering in the Canadian market, signaling expansion efforts.
PSA presents a cautious outlook with a consensus price target of $328.33 implying upside, yet technical indicators and cash flow concerns weigh. Investment opportunities lie in its high margins and dividend yield, while risks include operational execution amid interest rate sensitivity and competitive pressures in the REIT sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →